CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

Data Compilation
#PharmaFlow

Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

Stock Recap
#PipelineProspector

Aldalix

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 20 USDMF, 8 CEP/COS, 3 JDMF, 2 EU WC, 18 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

61 Drugs in Development

61 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

401 FDF Dossiers, 99 FDA Orange Book, 156 Europe, 27 Canada, 30 Australia, 38 South Africa, 51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 80MG, INJECTABLE;INJECTION - 10MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 6 SPI Pharma, 1 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 5 Kirsch Pharma, 6 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 17 BASF, 1 CD Formulation, 6 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 14 Kerry, 2 Keval Exports, 13 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 26 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 28 Direct Compression, 25 Granulation, 19 Lubricants & Glidants, 18 Thickeners and Stabilizers, 17 Parenteral, 17 Disintegrants & Superdisintegrants, 15 Film Formers & Plasticizers, 13 Co-Processed Excipients, 12 Taste Masking, 10 Coating Systems & Additives, 9 Solubilizers, 8 Controlled & Modified Release, 8 Chewable & Orodispersible Aids, 8 Topical, 5 Emulsifying Agents, 3 API Stability Enhancers, 1 Rheology Modifiers, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 38 News #PharmaBuzz

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 89 Regulatory FDF Prices, 6 Annual Reports

MARKET PLACE

42 APIs, 40 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 1 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 4 JP, 15 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
31/10/2025	EUROAPI	France	EUROAPI GERMANY GMBH	11785	FUROSEMIDE (BULK)	1995-12-18	Active	II	N/A
31/10/2025	TAPI Technology & API Services	Israel	TAPI NL BV	2565	FUROSEMIDE USP	1975-11-12	Active	II	Complete	2013-11-20	2013-11-05

Aldalix

Aldalix

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers

20 USDMF

8 CEP/COS

3 JDMF

2 EU WC

18 NDC API

23 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

61 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

401 FDF Dossiers

99 FDA Orange Book

156 Europe

27 Canada

30 Australia

38 South Africa

51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG

TABLET;ORAL - 40MG

TABLET;ORAL - 80MG

INJECTABLE;INJECTION - 10MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Rochem International Inc

6 SPI Pharma

1 DKSH

4 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

5 Kirsch Pharma

6 Actylis

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

17 BASF

1 CD Formulation

6 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Ideal Cures

3 Ingredion Pharma Solutions

14 Kerry

2 Keval Exports

13 Microlex e.U

2 Nitika Pharmaceutical Specialities

1 Novo Excipients

3 Pharmatrans-Sanaq

7 Pluviaendo

3 Prachin Chemical

26 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

3 Silverline Chemicals

1 Ulanqab Kema New Material

1 Valens Pharmachem

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders

28 Direct Compression

25 Granulation

19 Lubricants & Glidants

18 Thickeners and Stabilizers

17 Parenteral

17 Disintegrants & Superdisintegrants

15 Film Formers & Plasticizers

INJECTABLE;INJECTION - 10MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons